reports
- Robert Sassoon
A Start-Up That Is Delivering Revenue and Profit
We hosted CEO and Co-Founder Junling Liu for a fireside chat on July 18, 2024. The discussion included an overview of 111’s business model, its strategic priorities, and target milestones in the short and longer term. Liu also described the competitive landscape, explaining how the company differentiates itself from the competition, and the market opportunity that presents itself to 111. This report contains a transcript of the conversation, which can be accessed on demand. The link is accessibl...
- Robert Sassoon
Initiating Coverage: A Leader in China's Digital Health Revolution
111 operates one of China’s most innovative B2B tech-enabled healthcare platforms. Stewarded by an innovative technology leadership team with supply chain management expertise, 111 is one of China’s leading B2B tech-enabled healthcare platforms, operating in an industry where barriers to entry are quite formidable for new entrants. 111’s comprehensive pharmaceutical supply chain ecosystem. 111 has developed an evolving digitalized model with the mission to reshape the entire value chain of China...
111 Announces Changes to its Board of Directors
111 Announces Changes to its Board of Directors SHANGHAI, China, May 16, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that Dr. Leon Lian Yong Chen has been appointed as a new member to the board of directors. Meanwhile, Mr. Harry Chi Hui will no longer serve as a director for personal reasons. Both changes will be effective immediately. Dr. Chen is CEO and a founding partner of 6 Dimensions Capital, a major healthcare investment firm with coverage across China and the United States...
111, Inc. Announces First Quarter 2019 Unaudited Financial Results
111, Inc. Announces First Quarter 2019 Unaudited Financial Results SHANGHAI, China, May 16, 2019 (GLOBE NEWSWIRE) -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the first quarter ended March 31, 2019. First Quarter 2019 Highlights Net revenues were RMB655.6 million (US$97.7 million), representing an increase of 98.5% year-over-year. Operating expenses1 were RMB139.8 million (US$20.8 million), representing an increase of 67.8% year-over-year. Operating expenses a...
111, Inc. to Attend the HSBC 6th Annual China Conference in Shenzhen M...
111, Inc. to Attend the HSBC 6th Annual China Conference in Shenzhen May 15-17, 2019 SHANGHAI, China, May 13, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that the Company will participate in the HSBC 6th Annual China Conference in Shenzhen May 15-17, 2019. Dr. Gang Yu, Co-Founder and Executive Chairman of 111, is scheduled to participate in a panel discussion on China Pharmaceuticals: distribution trends and the role of new platforms on May 16. Dr. Yu will also be available to meet ...
111 to Announce First Quarter 2019 Unaudited Financial Results on May ...
111 to Announce First Quarter 2019 Unaudited Financial Results on May 16, 2019 SHANGHAI, China, April 26, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform in China, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2019, before the open of U.S. markets on Thursday, May 16, 2019. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, May 16, 2019 (7:30 PM Beijing Time on the same day). Dial-in detai...
111 Co-hosted and Presented at the “Internet + Healthcare†Develop...
111 Co-hosted and Presented at the “Internet + Healthcare” Development Summit during World Health Expo SHANGHAI, China, April 10, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that it co-hosted the “Internet + Healthcare” Development Summit (the “Summit”) with the Huangpi District Government, in Wuhan, Hubei Province, China, during the World Health Expo. The Company was also invited to present at the Summit to discuss new trends, business models and ecosystem in the healthcare industry...
111 Files Annual Report on Form 20-F for Fiscal Year 2018
111 Files Annual Report on Form 20-F for Fiscal Year 2018 SHANGHAI, China, April 10, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2018 with the U.S. Securities and Exchange Commission ("SEC") on April 10, 2019. The annual report can be accessed on the Company's investor relations website at as well as the SEC's website at . The Company will provide a hard copy of its annual report containin...
111, Inc. Announces Fourth Quarter and Fiscal Year 2018 Unaudited Fina...
111, Inc. Announces Fourth Quarter and Fiscal Year 2018 Unaudited Financial Results SHANGHAI, China, March 07, 2019 (GLOBE NEWSWIRE) -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2018. Fourth Quarter 2018 Highlights Net revenues were RMB557.4 million (US$81.1 million), representing an increase of 102.1% year-over-year. Operating expenses1 were RMB155.3 million (US$22.6 million), representing an increase of 7...
111, Inc. Announces the Appointment of a New Chief Financial Officer
111, Inc. Announces the Appointment of a New Chief Financial Officer SHANGHAI, China, Feb. 27, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (Nasdaq: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that Mr. Yang Chen has been appointed as Chief Financial Officer, effective immediately on February 27, 2019. Before joining 111, Mr. Chen served as Chief Financial Officer of iKang Healthcare Group Inc. (NASDAQ: KANG) from April 2013 to February 2019. Prior to that, Mr. Chen was Vice President of Finance and Strategy at Campbell Soup Asia Limite...
111 to Announce Fourth Quarter and Fiscal Year 2018 Unaudited Financia...
111 to Announce Fourth Quarter and Fiscal Year 2018 Unaudited Financial Results on March 7, 2019 SHANGHAI, China, Feb. 26, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2018, before the open of U.S. markets on Thursday, March 7, 2019. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, March 7, 2019 (8:30 PM Beijing Ti...
111, Inc. to Collaborate with Lilly in Creating New Solutions for Phar...
111, Inc. to Collaborate with Lilly in Creating New Solutions for Pharmaceutical Distribution SHANGHAI, China, Jan. 28, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) (“111” or the “Company”), a leading integrated online and offline healthcare platform, today announced it has signed a strategic cooperation memorandum of understanding with Eli Lilly and Company (NYSE: LLY) (“Lilly”), a global healthcare leader, to roll out a “fourth sales channel” solution for pharmaceutical companies by focusing on big data, e-prescriptions, doctor services, and patient education. Both parties will also ...
111, Inc. Announces Management and Board Changes
111, Inc. Announces Management and Board Changes SHANGHAI, China, Jan. 18, 2019 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) (“111” or the “Company”), a leading integrated online and offline healthcare platform in China, today announced that Mr. Weihao Xu has resigned as Chief Financial Officer and director for personal reasons. The Company has begun a process to appoint a successor to Mr. Xu and a further announcement will be made in due course. Mr. Xu will stay until March 7, 2019 to help with the transition. “I would like to thank Weihao for his substantial contribution to the Company...
111, Inc. Hosts Online Pharmaceuticals and Healthcare Summit to Look a...
111, Inc. Hosts Online Pharmaceuticals and Healthcare Summit to Look at the Future of Healthcare in China in the Internet Age SHANGHAI, China, Dec. 10, 2018 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, hosted the 2018 China Online Pharmaceuticals and Healthcare Summit (the “Summit”) and the General Suppliers Meeting in Shanghai on December 7, 2018. Organized by 111, Inc., the world’s largest virtual pharmacy network, the summit underlined the extraordinary potential of healthcare delivery in the internet...
111, Inc. Partners with Manulife-Sinochem to Establish Online Pharmacy...
111, Inc. Partners with Manulife-Sinochem to Establish Online Pharmacy + Health Insurance Model SHANGHAI, China, Dec. 04, 2018 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced it has established a strategic partnership with Manulife-Sinochem, the first foreign-invested joint venture life insurance company in China. Together the companies will establish a health management ecosystem integrating insurance with pharmacy benefits management and clinical services. Manulife-Sinochem is the first ins...
111, Inc. Announces Third Quarter 2018 Unaudited Financial Results
111, Inc. Announces Third Quarter 2018 Unaudited Financial Results SHANGHAI, China, Nov. 08, 2018 (GLOBE NEWSWIRE) -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the third quarter ended September 30, 2018. Third Quarter 2018 Highlights Net revenues were RMB497.6 million (US$72.5 million), representing an increase of 100.3% year-over-year. Operating expenses1 was RMB145.5 million (US$21.2 million), representing an increase of 61.3% year-over year. Number of pharm...
111, Inc. Establishes Strategic Partnership with A. Menarini China Hol...
111, Inc. Establishes Strategic Partnership with A. Menarini China Holding Co., Ltd SHANGHAI, China, Nov. 02, 2018 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced it has established a strategic partnership with A. Menarini China Holding Co., Ltd (“Menarini”), the subsidiary of Menarini Group in China. Menarini Group is the world’s largest Italian biopharmaceutical company and is present in over 130 countries worldwide. 111 will work together with Menarini to develop new retail distribution ch...
111, Inc. to Announce Third Quarter 2018 Financial Results on November...
111, Inc. to Announce Third Quarter 2018 Financial Results on November 8, 2018 SHANGHAI, China, Nov. 01, 2018 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2018, before the open of U.S. markets on Thursday, November 8, 2018. 111's management team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, November 8, 2018 (8:30 PM Beijing Time on November 8, 2018). Di...
111, Inc. Establishes Strategic Partnerships with Mentholatum China an...
111, Inc. Establishes Strategic Partnerships with Mentholatum China and Zhongxin Pharmaceuticals SHANGHAI, China, Oct. 25, 2018 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ:YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced it has established strategic partnerships with Mentholatum (China) Pharmaceuticals Co., Ltd (“Mentholatum China”), the Chinese branch of The Mentholatum Company, a global health and wellness company, and Tianjin Zhongxin Pharmaceuticals Group Co., Ltd. (“Zhongxin Pharmaceuticals”) (SHSE: 600329, SGX:T14), a producer of t...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.